32 related articles for article (PubMed ID: 16310250)
1. N-Formyl-Perosamine Surface Homopolysaccharides Hinder the Recognition of Brucella abortus by Mouse Neutrophils.
Mora-Cartín R; Chacón-Díaz C; Gutiérrez-Jiménez C; Gurdián-Murillo S; Lomonte B; Chaves-Olarte E; Barquero-Calvo E; Moreno E
Infect Immun; 2016 Jun; 84(6):1712-21. PubMed ID: 27001541
[TBL] [Abstract][Full Text] [Related]
2. A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer.
Elvington M; Huang Y; Morgan BP; Qiao F; van Rooijen N; Atkinson C; Tomlinson S
Blood; 2012 Jun; 119(25):6043-51. PubMed ID: 22442351
[TBL] [Abstract][Full Text] [Related]
3. Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis.
Woehrl B; Brouwer MC; Murr C; Heckenberg SG; Baas F; Pfister HW; Zwinderman AH; Morgan BP; Barnum SR; van der Ende A; Koedel U; van de Beek D
J Clin Invest; 2011 Oct; 121(10):3943-53. PubMed ID: 21926466
[TBL] [Abstract][Full Text] [Related]
4. Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4.
Bumbaca D; Wong A; Drake E; Reyes AE; Lin BC; Stephan JP; Desnoyers L; Shen BQ; Dennis MS
MAbs; 2011; 3(4):376-86. PubMed ID: 21540647
[TBL] [Abstract][Full Text] [Related]
5. Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease.
Fonseca MI; Chu SH; Berci AM; Benoit ME; Peters DG; Kimura Y; Tenner AJ
J Neuroinflammation; 2011 Jan; 8(1):4. PubMed ID: 21235806
[TBL] [Abstract][Full Text] [Related]
6. Expression of complement system components during aging and amyloid deposition in APP transgenic mice.
Reichwald J; Danner S; Wiederhold KH; Staufenbiel M
J Neuroinflammation; 2009 Nov; 6():35. PubMed ID: 19917141
[TBL] [Abstract][Full Text] [Related]
7. Comparison of immunopathology and locomotor recovery in C57BL/6, BUB/BnJ, and NOD-SCID mice after contusion spinal cord injury.
Luchetti S; Beck KD; Galvan MD; Silva R; Cummings BJ; Anderson AJ
J Neurotrauma; 2010 Feb; 27(2):411-21. PubMed ID: 19831737
[TBL] [Abstract][Full Text] [Related]
8. Deficiency in complement C1q improves histological and functional locomotor outcome after spinal cord injury.
Galvan MD; Luchetti S; Burgos AM; Nguyen HX; Hooshmand MJ; Hamers FP; Anderson AJ
J Neurosci; 2008 Dec; 28(51):13876-88. PubMed ID: 19091977
[TBL] [Abstract][Full Text] [Related]
9. The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration.
Alexander JJ; Anderson AJ; Barnum SR; Stevens B; Tenner AJ
J Neurochem; 2008 Dec; 107(5):1169-87. PubMed ID: 18786171
[TBL] [Abstract][Full Text] [Related]
10. Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV.
Minard-Colin V; Xiu Y; Poe JC; Horikawa M; Magro CM; Hamaguchi Y; Haas KM; Tedder TF
Blood; 2008 Aug; 112(4):1205-13. PubMed ID: 18495955
[TBL] [Abstract][Full Text] [Related]
11. Quantitative estimation of serum Ss level: changes upon the development of autoantibodies, environment and acute inflammation in inbred mice.
Natsuume-Sakai S; Kondo K; Migita S
Jpn J Exp Med; 1977 Apr; 47(2):117-23. PubMed ID: 864862
[TBL] [Abstract][Full Text] [Related]
12. Complement and demyelinating disease: no MAC needed?
Barnum SR; Szalai AJ
Brain Res Rev; 2006 Aug; 52(1):58-68. PubMed ID: 16443278
[TBL] [Abstract][Full Text] [Related]
13. Opsonic and nonopsonic interactions of C3 with Streptococcus pneumoniae.
Hostetter MK
Microb Drug Resist; 1999; 5(2):85-9. PubMed ID: 10432269
[No Abstract] [Full Text] [Related]
14. Complement in BuB/BnJ mice revisited: serum C3 levels and complement opsonic activity are not elevated.
Osmers I; Szalai AJ; Tenner AJ; Barnum SR
Mol Immunol; 2006 Apr; 43(10):1722-5. PubMed ID: 16310250
[TBL] [Abstract][Full Text] [Related]
15. Analysis of high complement levels in Mus hortulanus and BUB mice.
Ong GL; Baker AE; Mattes MJ
J Immunol Methods; 1992 Sep; 154(1):37-45. PubMed ID: 1401942
[TBL] [Abstract][Full Text] [Related]
16. Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.
Lew PD; Zubler R; Vaudaux P; Farquet JJ; Waldvogel FA; Lambert PH
J Clin Invest; 1979 Feb; 63(2):326-34. PubMed ID: 429556
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
